1. Home
  2. KNF vs TMDX Comparison

KNF vs TMDX Comparison

Compare KNF & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNF
  • TMDX
  • Stock Information
  • Founded
  • KNF 1917
  • TMDX 1998
  • Country
  • KNF United States
  • TMDX United States
  • Employees
  • KNF N/A
  • TMDX N/A
  • Industry
  • KNF
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • KNF
  • TMDX Health Care
  • Exchange
  • KNF Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • KNF 5.3B
  • TMDX 4.8B
  • IPO Year
  • KNF N/A
  • TMDX 2019
  • Fundamental
  • Price
  • KNF $78.63
  • TMDX $129.15
  • Analyst Decision
  • KNF Strong Buy
  • TMDX Buy
  • Analyst Count
  • KNF 6
  • TMDX 10
  • Target Price
  • KNF $117.17
  • TMDX $127.33
  • AVG Volume (30 Days)
  • KNF 820.6K
  • TMDX 808.7K
  • Earning Date
  • KNF 08-05-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • KNF N/A
  • TMDX N/A
  • EPS Growth
  • KNF 1.95
  • TMDX N/A
  • EPS
  • KNF 3.18
  • TMDX 1.41
  • Revenue
  • KNF $2,922,886,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • KNF $15.00
  • TMDX $34.07
  • Revenue Next Year
  • KNF $7.17
  • TMDX $20.76
  • P/E Ratio
  • KNF $25.34
  • TMDX $91.70
  • Revenue Growth
  • KNF 2.48
  • TMDX 64.43
  • 52 Week Low
  • KNF $67.22
  • TMDX $55.00
  • 52 Week High
  • KNF $108.83
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • KNF 39.61
  • TMDX 51.09
  • Support Level
  • KNF $79.21
  • TMDX $120.36
  • Resistance Level
  • KNF $85.04
  • TMDX $136.63
  • Average True Range (ATR)
  • KNF 3.33
  • TMDX 6.03
  • MACD
  • KNF 0.22
  • TMDX -1.68
  • Stochastic Oscillator
  • KNF 42.87
  • TMDX 35.12

About KNF Knife Riv Holding Co.

Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: